Palisade Capital Management »

Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Palisade Capital Management

Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Palisade Capital Management from 13F filings

Historical chart of Palisade Capital Management investment in Sarepta Therapeutics Inc Note 1.250 9/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by Palisade Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by Palisade Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $2.3M 1.8M 1.29
2024-03-31 $2.1M 1.8M 1.17
2023-12-31 $2.1M 2.1M 1.01
2023-09-30 $2.3M 2.1M 1.12

More positions owned by Palisade Capital Management

Raymond James Financial (RJF)
Mueller Industries (MLI)
Applied Industrial Technologies (AIT)
Apple (AAPL)
Avient Corp (AVNT)
Littelfuse (LFUS)
Primo Water (PRMW)
Ida (IDA)
Texas Roadhouse (TXRH)
Verra Mobility Corp Cl A Com Stk (VRRM)
ACI Worldwide (ACIW)
Blackbaud (BLKB)
Onto Innovation (ONTO)
Acadia Healthcare (ACHC)
Rli (RLI)

View all positions for Palisade Capital Management

Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1

Ing Investment Management
Highbridge Capital Management
Calamos Advisors
Tenor Capital Management
Davidson Kempner Capital Management
Advent Capital Management
Steelhead Partners
Lazard Asset Management
BlackRock
Magnetar Financial
State Street Corporation
OZ Management
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Lord, Abbett & Co
Bnp Paribas Arbitrage, Snc

View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1